OBM Drilchem Resultados de beneficios anteriores
Pasado controles de criterios 5/6
OBM Drilchem has been growing earnings at an average annual rate of 44.2%, while the Chemicals industry saw earnings growing at 9.7% annually. Revenues have been growing at an average rate of 26.2% per year. OBM Drilchem's return on equity is 16.9%, and it has net margins of 16.6%.
Información clave
44.2%
Tasa de crecimiento de los beneficios
36.3%
Tasa de crecimiento del BPA
| Crecimiento de la industria Chemicals | 9.0% |
| Tasa de crecimiento de los ingresos | 26.2% |
| Rentabilidad financiera | 16.9% |
| Margen neto | 16.6% |
| Última actualización de beneficios | 30 Jun 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Desglose de ingresos y gastos
Cómo gana y gasta dinero OBM Drilchem. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Jun 24 | 165,081 | 27,409 | 92,264 | 0 |
| 31 Mar 24 | 171,293 | 33,963 | 82,819 | 0 |
| 31 Dec 23 | 154,489 | 24,386 | 82,374 | 0 |
| 30 Sep 23 | 149,048 | 31,402 | 83,549 | 0 |
| 30 Jun 23 | 130,759 | 18,789 | 82,002 | 0 |
| 31 Mar 23 | 112,379 | 10,842 | 79,244 | 0 |
| 31 Dec 22 | 103,324 | 7,989 | 75,957 | 0 |
| 31 Dec 21 | 66,883 | 4,549 | 50,528 | 0 |
| 31 Dec 20 | 59,988 | 7,287 | 43,503 | 0 |
Ingresos de calidad: OBMD has high quality earnings.
Margen de beneficios creciente: OBMD's current net profit margins (16.6%) are higher than last year (14.4%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: OBMD's earnings have grown significantly by 44.2% per year over the past 5 years.
Acelerando crecimiento: OBMD's earnings growth over the past year (45.9%) exceeds its 5-year average (44.2% per year).
Beneficios vs. Industria: OBMD earnings growth over the past year (45.9%) exceeded the Chemicals industry 12.6%.
Rentabilidad financiera
Alta ROE: OBMD's Return on Equity (16.9%) is considered low.